Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and maximum tolerated dose,
pharmacokinetics, and anti-neoplastic response of AVN-944 in patients with advanced
hematologic malignancies.